1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. UNITED THERAPEUTICS CORP
United Therapeutics Corp XNAS: UTHR

United Therapeutics Corp Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on...

Read More
295.94 -1.62 (-0.54%)
29.17% Fall from 52W High
294.8K
XNAS Volume

XNAS 30 Jul, 2025 10:42 AM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for United Therapeutics Corp is on 31 Jul 2025 for the purpose of United Therapeutics Corp Second Quarter Earnings Results for 2025 See details
Durability score
High Financial Strength
55.6 / 100
Valuation Score
Mid Valuation
48.0 / 100
Momentum Score
Technically Neutral
47.5 / 100
Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM
Analyst Price Target
381
1Yr Price target upside is 29%
12 analysts

14

S

5

W

4

O

1

T

SWOT Analysis

United Therapeutics Corp Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..